Background: In studies on allergies in mouse models, IgE production is an essential parameter to be evaluated. Here, we examine the effect of commercially available immunoreaction enhancer solutions and different blocking reagents in enzyme-linked immunosorbent assay (ELISA) for total or antigen-specific murine IgE in order to improve the assays.
INTRODUCTION
Immediate hypersensitivity is caused by the release of mediators from mast cells and basophils activated through aggregation of the high-affinity IgE receptor (FcεRI) at the cell surface and allergen-specific IgE, crosslinked by multivalent allergens such as those derived from house dust mites, and pollen. 1, 2 Clini-cally, elevated levels of total or allergen-specific IgE in serum are a major manifestation of allergic diseases; therefore, in the study of allergies in mouse models, IgE production is an important parameter for evaluation.
Total IgE can be detected with a sandwich enzymelinked immunosorbent assay (ELISA) using a set of 2 anti-murine IgE monoclonal antibodies (mAbs). 3 Although weak signals for antigen-specific (Ag-specific) murine IgE have been a problem, we have recently reported on the enhancement of signal intensity in ELISA for murine IgE specific, not only to ovalbumin, but also recombinant forms of clinically relevant major mite allergens, using commercially available immunoreaction enhancer solutions. 4 Ag-specific IgE ELISA simply modified by enhancer solutions has remarkable advantages over conventional methods in terms of signal intensity and handling, even over a method with pretreatment of sera with protein Gcoupled beads. [4] [5] [6] However, further improvement of these assays for total IgE or Ag-specific IgE is necessary because, for example, only small volumes of sera can be collected intravenously from mice at intervals without causing death, particularly in younger mice, and the relatively long incubation time in modified Ag-specific IgE ELISA, which takes 3 days from coating plates with allergens to absorbance measurement, 4 still needs to be shortened.
Here, we examine the effect of enhancer solutions and different blocking reagents on ELISA for total or Ag-specific murine IgE, to improve the sensitivity for detection or the signal intensity, and to shorten the time required for the assay.
METHODS

RECOMBINANT Der f 1 AND Der p 1
Recombinant mature forms of house dust mite major group 1 allergens, Der f 1 and Der p 1, without (Der f 1-N53Q and Der p 1-N52Q) and with yeast-derived hyperglycosylation (Der f 1-WT and Der p 1-WT), were prepared as previously described. [7] [8] [9] [10] [11] Der f 1-N53Q (rDer f 1) and Der p 1-N52Q (rDer p 1) were used for immunization after incubation with Lcysteine. 3, 4, 12 Since B-cell epitopes for recombinant forms with and without hyperglycosylation are considered to be equivalent among natural Der f 1, rDer f 1, and Der f 1-WT and natural Der p 1, rDer p 1, and Der p 1-WT, 8, 9 we used hyperglycosylated Der p 1-WT and Der f 1-WT to detect Der p 1-and Der f 1specific Abs as alternatives to unglycosylated rDer p 1 and rDer f 1, respectively, the production of which is much less than that of the hyperglycosylated forms in yeast. 11
IMMUNIZATION OF MICE
Six-to-8-week-old female CBA! J mice were purchased from Charles River Japan, Inc. (Yokohama, Japan) and immunized as previously described. 3, 4, 12 Mice were given 4 weekly intraperitoneal injections of 0.5 or 1 μg of rDer f 1 or 1, 2, or 2.5 μg of rDer p 1 adsorbed on Alum (ImjectAlum; Pierce, Rockford, IL, USA). Sera collected at 1 week after the last injection were stored at −20 before assays. Sera used for the experiment in Figures 4, 6 were collected after the mice were challenged intranasally, twice with rDer p 1 (10 μg! head) 2 months after the last intraperitoneal injection.
IMMOBILIZATION OF MONOCLONAL ANTIBOD-IES AND ALLERGENS AND BLOCKING
Anti-murine IgE monoclonal antibodies (mAbs) (2 μg! ml, 50 μl! well) or allergens (10 μg! ml, 50 μl! well) were diluted with phosphate-buffered saline (PBS), and 96-well microtiter plates for ELISA (Max-iSorp; Nunc, Rockilde, Denmark) were incubated overnight with the allergen solutions at 4 . After 1 or 2 washes with PBS containing 0.05% (v! v) Tween 20 (PBST), the plates were incubated with BlockAce (BA) (DS Pharma Biomedical Co. Ltd., Osaka, Japan) diluted with pure water (1! 4 dilution), or with Im-munoBlock (IB) (DS Pharma Biomedical Co. Ltd.) diluted with pure water (1! 5 dilution) for 1.5 hours at 37 or 3 hours at room temperature (200 μl! well). After 2 washes with PBST, the plates were incubated with diluted sera.
ELISA FOR TOTAL IgE
The total concentration of IgE in the sera was measured by sandwich ELISA using a combination of a non-labeled anti-murine IgE mAb (clone R35 72; BD Biosciences, San Jose, CA, USA) and a horseradish peroxidase (HRP)-labeled anti-murine IgE mAb (clone LO-ME-2; Technopharm Biotechnology, Paris, France) or another non-labelled anti-murine IgE mAb (clone LOME-3; Technopharm Biotechnology), and HRP-labeled mAb (clone LOME-2) with murine monoclonal IgE specific to TNP (purified mouse IgE isotype control, clone IgE-3; BD Biosciences) as the standard. Volumes of 50 μl of standard IgE or sera diluted with Solution 1 of CanGetSignal (CGS1) (Toyobo, Osaka, Japan), PBST with 10% (v! v) BA (PBST-BA), or PBST with 5% (v! v) IB (PBST-IB) were added to the wells on the plates, which were coated with each of the anti-murine IgE mAbs and blocked as described above. Serum dilution factors were 200 or 1000. After incubation for 80 minutes at 37 and 3 5 washes with PBST, HRP-conjugated anti-murine IgE mAb (clone LO-ME-2) diluted with Solution 2 of CanGetSignal (CGS2) (Toyobo), PBST-BA, or PBST-IB was added to the plates (50 μl! well). After incubation for 80 minutes at 37 and 3 5 washes with PBST, the color was developed for 20 minutes using tetramethyl benzidine (BD-OptEIA kit; BD Biosciences) (100 μl! well), and the reaction was terminated by adding 2N sulfuric acid (50 μl! well). Optical density was measured at 450 nm, from which 
ELISA FOR Ag-specific IgE
Volumes of 50 μl of sera diluted with CGS1, PBST-BA, or PBST-IB were added to the wells on the plates, which were coated with allergens and blocked as described above. After incubation and 3 5 washes with PBST, HRP-conjugated anti-murine IgE mAb (clone LO-ME-2) diluted with CGS2, PBST-BA, or PBST-IB was added to the plates (50 μl! well). After incubation and 3 5 washes with PBST, color was developed and the reaction was terminated in a manner similar to the total IgE ELISA described above. Optical density at 450 nm, from which 570 nm was subtracted, was used as the signal for Ag-specific IgE.
Detailed conditions of the assay are described in the figure legends.
REMOVAL OF IgE FROM SERUM
Anti-IgE beads were prepared by covalent coupling of anti-murine IgE mAb (clone R35 72) to CNBr-activated Sepharose 4B beads and used to remove IgE from sera, as described previously. 4 Sera treated with control beads, with no protein coupling, were also prepared.
RESULTS
EFFECT OF BLOCKING REAGENTS AND EN-HANCER SOLUTIONS IN TOTAL IgE ELISA
The effect of blocking reagents (BA and IB) and enhancer solutions (CGS1 and CGS2) in sandwich ELISA for murine IgE was examined ( Fig. 1, 2 ). The use of CGS1 to dilute standard IgE did not affect the detection sensitivity and background absorbance in blank wells ( Fig. 1A, B , triangles). CGS2 to dilute the detection mAb improved detection sensitivity by approximately 30-fold but increased the background absorbance in blank wells ( Fig. 1A, B , circles). The increase in background absorbance was higher when using IB for blocking ( Fig. 1A, B , lower panels) than BA ( Fig. 1A, B , upper panels). Similar effects were observed when using both the 2 capture mAbs, R35 72 ( Fig. 1A ) and LOME-3 (Fig. 1B) . The dose- dependent curves in the 2 capture mAbs almost completely overlapped when using BA for blocking (Fig.  1C ). The results shown in Figure 1 indicate that using CGS2 to dilute the detection mAb is strikingly effective, that BA for blocking exhibits lower background absorbance in blank wells than blocking reagent IB, and that the 2 capture mAbs have similar potential.
Concentrations of capture and detection mAbs when using CGS1 to dilute standard IgE, and CGS2 to dilute detection mAb, were examined (Fig. 2 ). The background absorbance in blank wells to which no standard IgE was added ( Fig. 2 , IgE: 0 ng! ml) decreased, corresponding to the decrease in the concentrations of capture ( Fig. 2A ) and detection mAbs ( Fig. 2B ) particularly when using IB for blocking ( Fig. 2 , lower panels). The results shown in Figure 2 suggest that the increase in background absorbance when using CGS2 to dilute detection mAb ( Fig. 1A , B) could be due to the enhancement of direct binding of detection mAb to immobilized capture mAb.
COMPARISON OF IgE CONCENTRATIONS DE-TERMINED BY TOTAL IgE ELISAs USING CON-VENTIONAL BUFFERS AND ENHANCER SOLU-TIONS
According to the results shown in Figures 1, 2 , we considered the following conditions for total IgE ELISA to be the optimum: 2 μg! ml for the concentra-tion of capture mAb R35 72, BA for blocking, CGS1 for dilution of standard IgE and sera, and CGS2 for dilution (1! 4000 dilution) of the capture mAb. We examined whether these conditions were suitable to measure total IgE in mouse sera by comparing with conventional assay conditions previously described 3 (Fig. 3 ). Detection sensitivity improved by approximately 30-fold when using the enhancer solutions (Fig. 3A) . The determined IgE concentrations in 30 individual sera from mice immunized with rDer f 1 or rDer p1 were almost identical for both conventional (Fig. 3B , PBST-BA) and improved assay conditions (Fig. 3B, CGS) . The results indicate that the improved assay condition is suitable for measurement of total IgE.
EFFECT OF BLOCKING REAGENTS AND BUFF-ERS ON DILUTION OF SERA AND DETECTION mAb IN Ag-specific IgE ELISA
The effect of blocking reagents and enhancer solutions in ELISA for murine Ag-specific IgE in pooled serum from mice immunized with rDer p 1, used in our previous study 4 (Fig. 4) , or from mice immunized with rDer f 1 (Fig. 5) , was examined. Previously, we reported that the use of enhancer solutions, CGS1 and CGS2, significantly enhanced the signal intensity in Ag-specific IgE ELISA, when BA was used for blocking. 4 When using CGS2 to dilute the detection mAb ( Fig. 4 ), signal intensity was increased when us- ing IB for blocking ( Fig. 4B ), CGS1 for serum dilution ( Fig. 4C ), or a combination of both ( Fig. 4D ). Compared with previously published data, 4 CGS2 for dilution of detection mAb was effective to enhance the signal intensity even when using BA for blocking and PBST-BA for serum dilution (Fig. 4A ). Isotype specificity for IgE was confirmed using a pooled serum treated with anti-IgE beads (Fig. 4 , Anti-IgE). When using IB for blocking ( Fig. 5 ), CGS2 used to dilute detection mAb was extremely effective in increasing signal intensity (Fig. 5C, D) . However, compared with the marked enhancement observed by using CGS2 to dilute the capture mAb, CGS1 for serum dilution was not so effective.
EFFECT OF BLOCKING REAGENTS AND INCU-BATION TIME IN Ag-specific IgE ELISA USING ENHANCER SOLUTIONS
As IB for blocking was more effective for signal enhancement than BA (Fig. 4, 5) , we further examined the effect of IB to shorten the incubation time ( Fig. 6,   7 ). Using the anti-Der p 1 pooled serum from Figure  4 , the effect of IB (Fig. 6B , C) in 2 incubation schedules was compared with that of BA in a previous condition ( Fig. 6A ). When following the same schedule for the duration of incubation (overnight for serum and 5 hours for detection mAb), blocking with IB ( Fig. 6B ) enhanced signal intensity more than blocking with BA ( Fig. 6A) , although nonspecific binding of IgE to the plate was also enhanced by adding anti-TNP IgE (10 μg! ml and 100 μg! ml) to the pooled serum from vehicle-treated mice (Fig. 6B, Vehicle) . Blocking with IB under a shortened incubation schedule (2 hours for serum and 2 hours for detection mAb) ( Fig. 6C) , showed similar signal intensity to blocking with BA under the longer schedule ( Fig.  6A ) without enhancement of nonspecific IgE binding to the plate.
Using 35 individual sera from mice immunized with rDer f 1 (Fig. 7A ) or rDer p 1 (Fig. 7B) , we examined whether the conditions using IB for blocking are suitable for detection of Ag-specific IgE by com- paring them with assay conditions using BA. Overall, the order of signals for the sera was similar among the conditions tested ( Fig. 7) . Signal intensity was at its highest when blocking with IB, a 15-hour incubation with sera, and a 5-hour incubation with detection mAb. In addition, 2 other conditions (blocking with BA, 15-hour incubation with sera, and 5-hour incubation with detection mAb; and blocking with IB, 15hour incubation with sera, and 2-hour incubation with detection mAb) showed a similar signal intensity, and the shortest condition (blocking with IB, 2-hour incubation with sera, and 2-hour incubation with detection mAb) showed a similar or slightly less signal intensity. The results indicate that the assay conditions using IB for blocking are most suited to detect Agspecific IgE.
DOSE-DEPENDENCY OF ABSORBANCE WITH Ag-concentration IN THE Ag-immobilization STEP
Using the anti-Der p 1 pooled serum from Figures 4,  6 , we examined the dose-dependency of absorbance with Ag-concentration in the Ag-immobilization step ( Fig. 8) . Absorbance increased in a dose-dependent manner in the short assay condition (blocking with IB, 2-hour incubation with sera, and 2-hour incubation with detection mAb) using the enhancer solutions ( Fig. 8 , solid dots with solid lines). Without the use of enhancer solutions, a dose-dependent increase of absorbance was very small (Fig. 8A, triangles) . Pooled serum from vehicle-treated mice (Fig. 8B , Vehicle, circles with broken lines) showed similar absorbance levels to that when no additions of serum were made (Fig. 8B, No serum) .
DISCUSSION
When studying allergies in mouse models, IgE production is an important parameter for evaluation. In this study, we examined the effect of enhancer solutions and different blocking reagents on ELISA for total or Ag-specific murine IgE, in order to improve the detection sensitivity or signal intensity or to shorten the time of the assay. The application of enhancer solutions was effective in improving ELISAs for total ( Fig. 1 3) and Ag-specific murine IgE (Fig. 4 8) . Selection of blocking reagents was important to de- crease unwanted enhancement of the background signal in total IgE ELISA ( Fig. 1, 2) and was effective in enhancing signals for positive samples in Agspecific IgE ELISA (Fig. 4, 6, 7) . The sensitivity of total IgE ELISA was improved to approximately 30-fold with enhancer solutions (Fig. 1A, B, 3A) . Previously, we reported on signal enhancement in Ag-specific IgE ELISA using enhancer solutions, yet the assay took 3 days from coating plates with allergens to absorbance measurement. 4 However, by combining with another blocking reagent, IB, in the present study, we achieved similar signal intensity levels even under assay conditions with a shorter incubation time (Fig. 6 8) .
In total IgE ELISA, sensitivity was improved by ap-proximately 30-fold compared with our previous assay 4 (Fig. 1A, B, 3A) . The use of CGS2 to dilute the detection mAb critically contributes to improvement, and BA for blocking shows lower background absorbance in blank wells than another blocking reagent IB (Fig. 1) . The increase of background absorbance with CGS2 to dilute detection mAb (Fig. 1A, B ) could be due to enhanced binding of the detection mAb to the immobilized capture mAb (Fig. 2) . The sensitivity improvement in the present study using HRP-labeled anti-murine IgE mAb for detection is equivalent to using a combination of biotinylated anti-murine IgE mAb and streptavidin! alkaline phosphatase conjugate for detection. 13 Although weak signals for Ag-specific murine IgE have been a problem, we recently reported the enhancement of signal intensity in ELISA for murine IgE specific not only to ovalbumin but also recombinant forms of clinically relevant major mite allergens using enhancer solutions. 4 CGS2 to dilute detection mAb was strikingly effective in increasing signal intensity ( Fig. 5) . Compared with the marked enhancement using CGS2 to dilute detection mAb, the effects observed using CGS1 for serum dilution were limited (Fig. 4, 5) . A combination of enhancer solutions and another blocking reagent, IB, achieved equivalent signal intensity even under assay conditions with a shorter incubation time (Fig. 6, 7) . Results using serum depleted of IgE (Fig. 4 ) or supplemented with IgE ( Fig. 6 ) support isotype specificity to IgE and indicate that the nonspecific binding of IgE to the plate is low under the conditions in Figure 6A , C, and that titration is useful for the appropriate evaluation of Agspecific IgE, even at higher IgE concentrations, under the conditions shown in Figure 6B . Blocking with IB under a shortened incubation schedule (2 hours for serum and 2 hours for detection mAb) ( Fig. 6C ) showed a similar signal intensity to blocking with BA under a longer incubation schedule ( Fig. 6A ) without significant enhancement of nonspecific IgE binding to the plate. Dose dependency of absorbance with Agconcentration in the Ag-immobilization step (Fig. 8 ) along with Figure 6C supports the fact that the binding of IgE to the plates is Ag-specific. Unwanted direct binding of the detection Ab to Ag proteins immobilized onto the plates differs among Ag proteins (unpublished data). In the present study, we showed data using sera from CBA! J mice because the strain indicated a higher total and Ag-specific IgE response even at a relatively low dose. 4 The use of enhancer solutions was also effective for signal enhancement in Ag-specific IgE within sera from BALB! c and C57BL! 6 mice (Ref. 4, in addition to unpublished data ) . We recommend optimization of Agconcentration in the immobilization process, incubation time, and blocking reagents according to the Ags and Ag-specific IgE titers of sera.
The results using individual sera from mice immunized with recombinant house dust mite major allergens before and after improvement indicate that the improved assay conditions are suitable for measurement of total IgE (Fig. 3) or Ag-specific IgE (Fig. 7) . Since only small amounts of sera can be collected intravenously from mice at intervals without causing death, particularly in younger mice, improvement in detection sensitivity and signal enhancement, even with extensive serum dilution, is beneficial. The IgE response specific to clinically relevant allergens other than ovalbumin, which has been frequently used in animal models of allergies, is an important issue to investigate because recent studies have suggested that allergen sources have specific properties to promote Th2 sensitization to IgE production or exacerbation processes. 3, 6, 12, [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] Ag-specific IgE ELISA with enhanced signal intensity for clinically relevant major allergens 4 (Fig. 4 8) is a strong tool for addressing this issue. The conditions recommended in this report are useful for studying allergies using mouse models.
